Skip to main content

Graybug Vision, Founded Out of Johns Hopkins University Expects to Raise $90M in IPO

Congratulations to Johns Hopkins University spinout company Graybug Vision on its Wall Street debut Friday! Graybug expects to use the anticipated $90-$100M proceeds from the IPO to continue development of drugs for ocular diseases that cause blindness. Founded in 2011 from groundbreaking research performed at JHU’s Wilmer Eye Institute, the biopharmaceutical company is based out of CA and maintains a research and development center in Baltimore. Collaboration with Johns Hopkins will continue as the company assesses expansion of research facilities following the new funding.

Read More

Michele Whelley - President & CEO

"We want you to be informed about Greater Baltimore. Don't be shy; please ask."

Michele Whelley
President & CEO

We are here to help you!

If you've landed on this site, then you have questions about us, and we want to help. We know that your time is crucial, and getting access to us should not be a complicated thing. Drop us a note via one of the options below and we will get back to you within 24 hours.

(410) 864-9927